Jeffrey Heier

Insider profile

Currently holds a position at Ocular Therapeutix, Inc.

Performance

Overall performance
3.7
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 28% 68% 82%
Transactions
11 18% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 149%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director Ocular Therapeutix, Inc. Sept. 11, 2015 -
Jeffrey Heier's trades of Ocular Therapeutix, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
96.33
Quantity 31,512
Value US$2,864,005
Transaction date
Planned sale
Price
289.50
Quantity 70,023 -39.9%
Value US$733,558
Transaction date
Proposed sale
Price
10.78
Quantity 3,296
Value US$35,532
Transaction date
Proposed sale
Price
8.20
Quantity 3,018
Value US$24,745
Transaction date
Proposed sale
Price
8.28
Quantity 3,057
Value US$25,298
Transaction date
Proposed sale
Price
12.04
Quantity 3,469
Value US$41,772
Transaction date
Proposed sale
Price
11.04
Quantity 10,502
Value US$115,890
Transaction date
Proposed sale
Price
12.04
Quantity 3,063
Value US$36,883
Transaction date
Proposed sale
Price
7.18
Quantity 3,024
Value US$21,707
Transaction date
Proposed sale
Price
6.87
Quantity 3,061
Value US$21,043
Transaction date
Proposed sale
Price
9.01
Quantity 2,948
Value US$26,550
Transaction date
Purchase
Price
4.15
Quantity 24,000 New position
Value US$99,600
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-06 2026-10-02
S Sale
2,441 +32.7%
180.82
US$3,805,067 		2,441 +32.7% 180.82 US$3,805,067
2026-10-02 2026-10-02
PrS Proposed sale
31,512
96.33
US$2,864,005 		31,512 96.33 US$2,864,005
2026-08-26 2026-08-24
PlS Planned sale
70,023 -39.9%
289.50
US$733,558 		70,023 -39.9% 289.50 US$733,558
2026-08-24 2026-08-24
PrS Proposed sale
3,296
10.78
US$35,532 		3,296 10.78 US$35,532
2026-05-28 2026-05-26
S Sale
3,018 -0.9%
8.20
US$24,748 		3,018 -0.9% 8.20 US$24,748
2026-05-26 2026-05-26
PrS Proposed sale
3,018
8.20
US$24,745 		3,018 8.20 US$24,745
2026-02-25 2026-02-23
S Sale
3,057 -0.9%
8.28
US$25,312 		3,057 -0.9% 8.28 US$25,312
2026-02-23 2026-02-23
PrS Proposed sale
3,057
8.28
US$25,298 		3,057 8.28 US$25,298
2025-11-26 2025-11-24
S Sale
3,469 -1.4%
12.04
US$41,767 		3,469 -1.4% 12.04 US$41,767
2025-11-24 2025-11-24
PrS Proposed sale
3,469
12.04
US$41,772 		3,469 12.04 US$41,772
2025-10-06 2025-10-02
S Sale
10,502 -4.0%
11.04
US$115,942 		10,502 -4.0% 11.04 US$115,942
2025-10-02 2025-10-02
PrS Proposed sale
10,502
11.04
US$115,890 		10,502 11.04 US$115,890
2025-08-27 2025-08-25
S Sale
3,063 -1.2%
12.04
US$36,879 		3,063 -1.2% 12.04 US$36,879
2025-08-25 2025-08-25
PrS Proposed sale
3,063
12.04
US$36,883 		3,063 12.04 US$36,883
2025-05-27 2025-05-23
S Sale
3,024 -1.1%
7.18
US$21,712 		3,024 -1.1% 7.18 US$21,712
2025-05-23 2025-05-23
PrS Proposed sale
3,024
7.18
US$21,707 		3,024 7.18 US$21,707
2025-02-26 2025-02-24
S Sale
3,061 -1.1%
6.87
US$21,029 		3,061 -1.1% 6.87 US$21,029
2025-02-24 2025-02-24
PrS Proposed sale
3,061
6.87
US$21,043 		3,061 6.87 US$21,043
2024-11-27 2024-11-25
S Sale
2,948 -1.1%
9.01
US$26,561 		2,948 -1.1% 9.01 US$26,561
2024-11-25 2024-11-25
PrS Proposed sale
2,948
9.01
US$26,550 		2,948 9.01 US$26,550
2022-05-16 2022-05-12
B Purchase
15,000 +62.5%
3.05
US$45,750 		15,000 +62.5% 3.05 US$45,750
2019-03-18 2019-03-15
B Purchase
24,000 New position
4.15
US$99,600 		24,000 New position 4.15 US$99,600